Małgorzata Talerczyk

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Claudia Allemani, Tomohiro Matsuda, V Di Carlo et al. · The Lancet · 2018 · 5.9K citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +11

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 174 citations · Full text

Concurrent Chemoradiotherapy, Neoadjuvant Therapy, Squamous Cell Carcinoma +6

Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy

Krzysztof Sieja, Małgorzata Talerczyk · Gynecologic Oncology · 2004 · 148 citations

Selenium Deficiency, Medicine, Cancer Management +5